Laparoscopic Robotic-assisted Procedures Market Size, Share & Trends Analysis Report By Application (General Surgery, Urology, Gynecology, Bariatric, Colorectal), By Procedure Complexity, By End-use, By Region, And Segment Forecasts, 2025 - 2033
Description
Laparoscopic Robotic-assisted Procedures Market Summary
The global laparoscopic robotic-assisted procedures market size was estimated at USD 7.33 billion in 2024 and is projected to reach USD 31.56 billion by 2033, growing at a CAGR of 17.71% from 2025 to 2033. The growing integration of advanced technology, broader application across different procedures, and rising institutional investment are propelling the use of laparoscopic surgical robotics.
Hospitals are adopting robotic systems in diverse specialties and types of procedures, supported by enhanced clinical validation and improved operational efficiency. These trends are leading to the standardization of surgical robotics within routine hospital workflows. For example, Summerlin Hospital Medical Center in Nevada, U.S., utilizes the da Vinci Surgical System to conduct robot-assisted laparoscopic surgeries for kidney patients.
The increasing demand for minimally invasive surgeries drives the adoption of laparoscopic surgical robots. Both patients and healthcare providers prioritize procedures that minimize trauma, promote faster recovery, and reduce complications. Robotic systems improve the precision and control necessary for these procedures, allowing surgeons to conduct complex maneuvers through smaller incisions. Furthermore, the market is experiencing growth due to increased product approvals. For instance, in October 2024, CMR Surgical received de novo clearance from the FDA for its Versius surgical system, which permits its modular, cart-based laparoscopic robot to be introduced in the U.S.
One of the key factors propelling the laparoscopic robotic-assisted procedures industry forward is the ability of laparoscopic surgical robot systems to reduce human errors in the operating room. These robotic systems provide stable hands and accurate movements, significantly reducing the risk of errors during complex surgical procedures. By enhancing visualization and dexterity, robotic platforms help address challenges such as hand tremors or fatigue that compromise the accuracy of procedures. For instance, over 1,700 da Vinci Systems were installed in healthcare facilities worldwide, with over 775,000 patients having undergone a procedure using the da Vinci system.
The increasing number of regulatory approvals and patent grants drives growth in the laparoscopic surgical robot sector by speeding up product launches and technological advancements. Efficient pathways provided by agencies such as the FDA and CE Mark have facilitated the quick introduction of technologically advanced laparoscopic surgical systems. For instance, in June 2024, the FDA granted clearance for the commercial version of Moon Surgical's Maestro system, a robotic platform designed to support and manipulate laparoscopic instruments during soft tissue surgeries. This clearance allows the system, which integrates NVIDIA Holoscan and AI-powered ScoPilot technology, to be used in US hospitals to enhance surgical precision and workflow efficiency in various procedures.
Global Laparoscopic Robotic-assisted Procedures Market Report Segmentation
This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global laparoscopic robotic-assisted procedures market report based on application, procedure complexity, end-use, and region:
The global laparoscopic robotic-assisted procedures market size was estimated at USD 7.33 billion in 2024 and is projected to reach USD 31.56 billion by 2033, growing at a CAGR of 17.71% from 2025 to 2033. The growing integration of advanced technology, broader application across different procedures, and rising institutional investment are propelling the use of laparoscopic surgical robotics.
Hospitals are adopting robotic systems in diverse specialties and types of procedures, supported by enhanced clinical validation and improved operational efficiency. These trends are leading to the standardization of surgical robotics within routine hospital workflows. For example, Summerlin Hospital Medical Center in Nevada, U.S., utilizes the da Vinci Surgical System to conduct robot-assisted laparoscopic surgeries for kidney patients.
The increasing demand for minimally invasive surgeries drives the adoption of laparoscopic surgical robots. Both patients and healthcare providers prioritize procedures that minimize trauma, promote faster recovery, and reduce complications. Robotic systems improve the precision and control necessary for these procedures, allowing surgeons to conduct complex maneuvers through smaller incisions. Furthermore, the market is experiencing growth due to increased product approvals. For instance, in October 2024, CMR Surgical received de novo clearance from the FDA for its Versius surgical system, which permits its modular, cart-based laparoscopic robot to be introduced in the U.S.
One of the key factors propelling the laparoscopic robotic-assisted procedures industry forward is the ability of laparoscopic surgical robot systems to reduce human errors in the operating room. These robotic systems provide stable hands and accurate movements, significantly reducing the risk of errors during complex surgical procedures. By enhancing visualization and dexterity, robotic platforms help address challenges such as hand tremors or fatigue that compromise the accuracy of procedures. For instance, over 1,700 da Vinci Systems were installed in healthcare facilities worldwide, with over 775,000 patients having undergone a procedure using the da Vinci system.
The increasing number of regulatory approvals and patent grants drives growth in the laparoscopic surgical robot sector by speeding up product launches and technological advancements. Efficient pathways provided by agencies such as the FDA and CE Mark have facilitated the quick introduction of technologically advanced laparoscopic surgical systems. For instance, in June 2024, the FDA granted clearance for the commercial version of Moon Surgical's Maestro system, a robotic platform designed to support and manipulate laparoscopic instruments during soft tissue surgeries. This clearance allows the system, which integrates NVIDIA Holoscan and AI-powered ScoPilot technology, to be used in US hospitals to enhance surgical precision and workflow efficiency in various procedures.
Global Laparoscopic Robotic-assisted Procedures Market Report Segmentation
This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global laparoscopic robotic-assisted procedures market report based on application, procedure complexity, end-use, and region:
- Application Outlook (Revenue USD Million, 2021 - 2033)
- General Surgery
- Urology
- Gynecology
- Colorectal
- Bariatric
- ENT (Otolaryngology)
- Others (Cardiothoracic, Thoracic, Pediatric)
- Procedure Complexity Outlook (Revenue USD Million, 2021 - 2033)
- High complexity
- Medium complexity
- Low complexity
- End-use Outlook (Revenue USD Million, 2021 - 2033)
- Large hospital systems (multi-facility)
- Standalone / private hospitals
- Specialty clinics / ASCs
- Other (Research / training centers)
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Procedure complexity outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Global Laparoscopic Robotic-Assisted Procedures Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Global Laparoscopic Robotic-Assisted Procedures: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTLE Analysis
- 3.4. Technology Landscape
- 3.5. Case Study Analysis
- Chapter 4. Global Laparoscopic Robotic-Assisted Procedures Market Segment Analysis, By Application, 2021 - 2033 (USD Million)
- 4.1. Definition and Scope
- 4.2. Application Market Share Analysis, 2024 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Laparoscopic Robotic-Assisted Procedures Market, by Application, 2021 to 2033
- 4.5. General Surgery
- 4.5.1. General Surgery market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6. Urology
- 4.6.1. Urology market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.7. Gynecology
- 4.7.1. Gynecology market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.8. Colorectal
- 4.8.1. Colorectal market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.9. Bariatric
- 4.9.1. Bariatric market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.10. ENT (Otolaryngology)
- 4.10.1. ENT (Otolaryngology) market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.11. Others (Cardiothoracic, Thoracic, Pediatric)
- 4.11.1. Others (Cardiothoracic, Thoracic, Pediatric) market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 5. Global Laparoscopic Robotic-Assisted Procedures Market Segment Analysis, By Procedure Complexity, 2021 - 2033 (USD Million)
- 5.1. Definition and Scope
- 5.2. Procedure Complexity Market Share Analysis, 2024 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Surgical Robot Procedures Market, by Procedure Complexity, 2021 to 2033
- 5.5. High Complexity
- 5.5.1. High complexity market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.6. Medium Complexity
- 5.6.1. Medium complexity market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.7. Low Complexity
- 5.7.1. Low complexity market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 6. Global Laparoscopic Robotic-Assisted Procedures Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)
- 6.1. Definition and Scope
- 6.2. End Use Market Share Analysis, 2024 & 2033
- 6.3. Segment Dashboard
- 6.4. Global Surgical Robot Procedures Market, by End Use, 2021 to 2033
- 6.5. Large hospital systems (multi-facility)
- 6.5.1. Large hospital systems (multi-facility) market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.6. Standalone hospitals / private hospitals
- 6.6.1. Standalone hospitals / private hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.7. Specialty clinics / ASCs
- 6.7.1. Specialty clinics / ASCs market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.8. Others
- 6.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 7. Laparoscopic Robotic-Assisted Procedures Market Segment Analysis, By Region, 2021 - 2033 (USD Million)
- 7.1. Regional Market Share Analysis, 2024 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Laparoscopic Robotic-Assisted Procedures Market Share by Region, 2024 & 2033:
- 7.5. North America
- 7.5.1. North America laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Scenario
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. U.S. laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.5.2.5. U.S. laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Scenario
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Canada laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.5.3.5. Canada laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Regulatory Scenario
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Mexico laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.5.4.5. Mexico laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6. Europe
- 7.6.1. Europe laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.2. UK
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Scenario
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. UK laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.2.5. UK laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6.3. Germany
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Scenario
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Germany laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.3.5. Germany laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Scenario
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. France laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.4.5. France laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Regulatory Scenario
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Italy laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.5.5. Italy laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6.6. Spain
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Regulatory Scenario
- 7.6.6.3. Competitive Scenario
- 7.6.6.4. Spain laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.6.5. Spain laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6.7. Norway
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Regulatory Scenario
- 7.6.7.3. Competitive Scenario
- 7.6.7.4. Norway laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.7.5. Norway laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6.8. Sweden
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Regulatory Scenario
- 7.6.8.3. Competitive Scenario
- 7.6.8.4. Sweden laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.8.5. Sweden laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.6.9. Denmark
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Regulatory Scenario
- 7.6.9.3. Competitive Scenario
- 7.6.9.4. Denmark laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.6.9.5. Denmark laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key Country Dynamics
- 7.7.1.2. Regulatory Scenario
- 7.7.1.3. Competitive Scenario
- 7.7.1.4. Japan laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.7.1.5. Japan laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.7.2. China
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Regulatory Scenario
- 7.7.2.3. Competitive Scenario
- 7.7.2.4. China laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.7.2.5. China laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.7.3. India
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Regulatory Scenario
- 7.7.3.3. Competitive Scenario
- 7.7.3.4. India laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.7.3.5. India laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.7.4. Australia
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Regulatory Scenario
- 7.7.4.3. Competitive Scenario
- 7.7.4.4. Australia laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.7.4.5. Australia laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.7.5. South Korea
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Regulatory Scenario
- 7.7.5.3. Competitive Scenario
- 7.7.5.4. South Korea laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.7.5.5. South Korea laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.7.6. Thailand
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Regulatory Scenario
- 7.7.6.3. Competitive Scenario
- 7.7.6.4. Thailand laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.7.6.5. Thailand laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key Country Dynamics
- 7.8.1.2. Regulatory Scenario
- 7.8.1.3. Competitive Scenario
- 7.8.1.4. Brazil laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.8.1.5. Brazil laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.8.2. Argentina
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Regulatory Scenario
- 7.8.2.3. Competitive Scenario
- 7.8.2.4. Argentina laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.8.2.5. Argentina laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key Country Dynamics
- 7.9.1.2. Regulatory Scenario
- 7.9.1.3. Competitive Scenario
- 7.9.1.4. South Africa laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.9.1.5. South Africa laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Regulatory Scenario
- 7.9.2.3. Competitive Scenario
- 7.9.2.4. Saudi Arabia laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.9.2.5. Saudi Arabia laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.9.3. UAE
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Regulatory Scenario
- 7.9.3.3. Competitive Scenario
- 7.9.3.4. UAE laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.9.3.5. UAE laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- 7.9.4. Kuwait
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Regulatory Scenario
- 7.9.4.3. Competitive Scenario
- 7.9.4.4. Kuwait laparoscopic robotic-assisted procedures market, 2021 - 2033 (USD Million)
- 7.9.4.5. Kuwait laparoscopic robotic-assisted procedures market, 2021 - 2033 (Procedure, Volume)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Intuitive Surgical
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. CMR Surgical
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Medtronic
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Asensus Surgical US, Inc.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. MicroPort (Shanghai MicroPort Medical (Group) Co. Ltd.)
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Stryker Corporation
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Titan Medical Inc.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Vicarious Surgical
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Distalmotion SA
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Virtual Incision
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.